To provide a guideline on sarcoidosis treatment.
Two members of the ELF sarcoidosis patient advisory group were nominated as members of the Task force working group. A survey to individuals with sarcoidosis was disseminated across Europe to rate the importance of a range of treatment outcomes and the findings will be incorporated into the final Task force report.
The guideline is due to be published in 2021.
An article by the sarcoidosis patient advisory group: Sarcoidosis: patient treatment priorities was published in ERJ Open Research in December 2018 and highlights the findings of our patient survey, the findings of which will be reflected in the final guideline.
ELF is a non-profit organisation registered as a UK company (VAT no. GB 115 0027 74) and charity (no. 1118930).
Our Brussels office enterprise number is 0738.383.695
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.